These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38347781)

  • 41. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Xu R; Yin S; Zheng M; Pei X; Ji X
    Dig Dis Sci; 2021 Dec; 66(12):4361-4373. PubMed ID: 33433801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
    Lu C; Fang S; Weng Q; Lv X; Meng M; Zhu J; Zheng L; Hu Y; Gao Y; Wu X; Mao J; Tang B; Zhao Z; Huang L; Ji J
    Cell Commun Signal; 2020 Jun; 18(1):97. PubMed ID: 32576292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis.
    Zhao Z; Gad H; Benitez-Buelga C; Sanjiv K; Xiangwei H; Kang H; Feng M; Zhao Z; Berglund UW; Xia Q; Helleday T
    Cancer Res; 2021 Aug; 81(15):4079-4093. PubMed ID: 34045188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma.
    Li M; Zhang X; Wang M; Wang Y; Qian J; Xing X; Wang Z; You Y; Guo K; Chen J; Gao D; Zhao Y; Zhang L; Chen R; Cui J; Ren Z
    Cancer Commun (Lond); 2022 Nov; 42(11):1162-1184. PubMed ID: 36181398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
    Chen W; Li Y; Zhong J; Wen G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrine suppresses hepatocellular carcinoma tumorigenesis by modulating circ_0055976/miR-1179/lactate dehydrogenase A axis.
    Chang X; Li H; Huang Z; Song C; Zhang Z; Pan W
    Environ Toxicol; 2024 Mar; 39(3):1481-1493. PubMed ID: 37994612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA
    Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
    Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcription Factor FOSL1 Promotes Angiogenesis of Colon Carcinoma by Regulating the VEGF Pathway Through Activating TIMP1.
    Wang M; Wang X; Zhang Y; Gu J; Zhang J; Wen X
    Biochem Genet; 2024 Oct; 62(5):3389-3402. PubMed ID: 38103125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.
    Wang X; Li N; Han A; Wang Y; Lin Z; Yang Y
    Cancer Sci; 2020 Nov; 111(11):4061-4074. PubMed ID: 32639665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 Axis.
    Lai Z; Wei T; Li Q; Wang X; Zhang Y; Zhang S
    Cancer Biother Radiopharm; 2023 Dec; 38(10):674-683. PubMed ID: 32907351
    [No Abstract]   [Full Text] [Related]  

  • 52. [Long non-coding RNA UPK1A-AS1 promotes glycolysis in hepatocellular carcinoma cells
    Zhang D; Zou X; Song Y; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Feb; 41(2):193-199. PubMed ID: 33624591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
    Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
    Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
    Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.
    Lu L; Huang J; Mo J; Da X; Li Q; Fan M; Lu H
    Cell Mol Biol Lett; 2022 Feb; 27(1):17. PubMed ID: 35193488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer.
    Chen CY; Wu SM; Lin YH; Chi HC; Lin SL; Yeh CT; Chuang WY; Lin KH
    Theranostics; 2019; 9(8):2361-2379. PubMed ID: 31149049
    [No Abstract]   [Full Text] [Related]  

  • 57. Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway.
    Xu B; Wei Y; Liu F; Li L; Zhou S; Peng Y; Li B
    Cell Death Discov; 2022 Aug; 8(1):348. PubMed ID: 35927226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
    Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
    J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
    Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
    J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.